Team:Washington/Gram Positive

From 2010.igem.org

(Difference between revisions)
(→Anthrax)
Line 38: Line 38:
CapD is naturally a transpeptidase, favoring reactions with amino acids to perform its task, cleaving PDGA. However, CapD would be invaluable as a hydrolase, reacting with water to cleave PDGA, because of the high levels of water in the human body. If a mutant CapD could be engineered as an extremely efficient hydrolase, it is theorized that a single dose of concentrated CapD into the blood stream would easily decimate anthrax populations, nullifying its lethal properties.
CapD is naturally a transpeptidase, favoring reactions with amino acids to perform its task, cleaving PDGA. However, CapD would be invaluable as a hydrolase, reacting with water to cleave PDGA, because of the high levels of water in the human body. If a mutant CapD could be engineered as an extremely efficient hydrolase, it is theorized that a single dose of concentrated CapD into the blood stream would easily decimate anthrax populations, nullifying its lethal properties.
-
 
-
=='''Other'''==
 
-
here's an outline from the 8/25 meeting.
 
-
the pages are set up based on it so far but feel free to change them
 
-
* Background (this page)
 
-
** Anthrax is bad
 
-
** Your immune system can't destroy it while its coating is intact
 
-
** Our protein takes off the coating
 
-
* Introduction/methods
 
-
** transpeptidase --> hydrolase
 
-
** protein engineering in foldit
 
-
** protein purification
 
-
** kunkel mutagenesis
 
-
** michaelis-menton (sp?) is replacing mutant data?
 
-
** protein expression vectors
 
-
* experimental results
 
-
** relative activities of variants
 
-
** do this page last because it will change as we go
 
-
 
-
something should point to Tom's vectors project... not sure where that goes best.
 
-
 
-
 
-
update 8/30:
 
-
* spend less time on kunkle mutagenesis
 
-
* divide process wheel, overall presentation, <b>this wiki</b> to "design --> build --> test"
 
-
* add youtube videos
 
-
* organize into treatment/therapeutics —> positive, negative
 
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->

Revision as of 21:50, 16 September 2010

Washington CapD Header Picture.jpg

Anthrax

Bacillus anthracis

Anthrax is a lethal disease caused by the bacterium Bacillus anthracis which can spread by ingestion, inhalation, or cutaneous lesion contact with spores. Spores of Bacillus anthracis are extremely resilient, remaining potent even after enduring the harshest climates for multiple centuries. This disease is not contagious, cannot be transferred from an infected organism, though bacterial spores can be transported in a multitude of ways and will infect potential victims.

CapD

CapD Protein Structure

Anthrax creates a poly-γ-D-glutamate (PDGA) capsule which prevents the immune system from recognizing it as a pathogen and performing phagocytosis to eliminate the threat. Naturally, anthrax produces CapD which cleaves and anchors the capsule to its peptidoglycan, the outer coat of the cell membrane; however, research shows that an overexpression of CapD will cleave the capsule, removing immunity to phagocytosis.

Goal

CapD is naturally a transpeptidase, favoring reactions with amino acids to perform its task, cleaving PDGA. However, CapD would be invaluable as a hydrolase, reacting with water to cleave PDGA, because of the high levels of water in the human body. If a mutant CapD could be engineered as an extremely efficient hydrolase, it is theorized that a single dose of concentrated CapD into the blood stream would easily decimate anthrax populations, nullifying its lethal properties.


← Overview       Designing the Gram(+) Therapeutic →

Retrieved from "http://2010.igem.org/Team:Washington/Gram_Positive"